Africa News Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Currents.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on November 10, 2025

November 10, 2025

غرينبيس الشرق الأوسط وشمال أفريقيا قبيل مؤتمر الأطراف 30، للالتزام بهدف 1.5° وتجنّب إخفاقات الماضي في مواجهة أزمة المناخ

EIN Presswire

November 10, 2025

Rakovina Therapeutics to Present New Data Highlighting CNS-Penetrant ATR and PARP1 Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting

GlobeNewswire

November 10, 2025

Codexis Announces Signing of Lease for GMP Manufacturing Facility

GlobeNewswire

November 10, 2025

AIM ImmunoTech Details New UPMC Abstract on Completed Clinical Trial Involving Ampligen’s Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer

GlobeNewswire

November 10, 2025

PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025

GlobeNewswire

November 10, 2025

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

GlobeNewswire

November 10, 2025

Clearmind Medicine Successfully Completed First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

GlobeNewswire

November 10, 2025

Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer

GlobeNewswire

November 10, 2025

Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025

GlobeNewswire

November 10, 2025

Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference

GlobeNewswire

November 10, 2025

ESGold Completes Montauban Mill Building Construction and Moves Toward Production Readiness

GlobeNewswire

November 10, 2025

Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors

GlobeNewswire

November 10, 2025

Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025

GlobeNewswire

November 10, 2025

Refined Energy Corp. Provides Corporate Update and Q1 2026 Exploration Plans

GlobeNewswire

November 10, 2025

Aventis Energy Bolsters Targets Along Uranium Trends at the Corvo Uranium Project with KorrAI Technologies

GlobeNewswire

November 10, 2025

Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market

GlobeNewswire

November 10, 2025

Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 10, 2025

Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer

GlobeNewswire

November 10, 2025

Bluejay Therapeutics’ Brelovitug (BJT-778) Monotherapy Achieved 100% Virologic Response and up to 82% Combined Endpoint of Virologic Response and ALT Normalization at Week 48 in Phase 2 Study in Chronic Hepatitis D (CHD)

GlobeNewswire

November 10, 2025

InflaRx Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU)

GlobeNewswire